Search
Elutia Inc
ELUTAdd to Watchlist
0.820USD
0.0000.00%
Market hours 09/25, 11:19（ET）
36.25MMarket Cap
0.67P/E TTM
About Elutia Inc Company
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Women’s Health and Cardiovascular markets. In Women’s Health, it offers SimpliDerm, a novel biological matrix that leverages the inherent science of natural healing processes. SimpliDerm's design uses human-based hydrated acellular dermal matrix (ADM), which mitigates inflammation and enhances tissue incorporation. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population. It is focused on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines biologics and extended antibiotic release to provide protection while supporting tissue regeneration.
Elutia Inc Profile
Ticker SymbolELUT
Company nameElutia Inc
IPO dateOct 08, 2020
CEOMills (C. Randal)
Number of employees51
Security typeOrdinary Share
Fiscal year-endOct 08
Address12510 Prosperity Drive
CitySILVER SPRING
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code20904
Phone12402471143
Websitehttps://elutia.com/
Ticker SymbolELUT
IPO dateOct 08, 2020
CEOMills (C. Randal)
Company Executives of Elutia Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Matthew B. (Matt) Ferguson
Mr. Matthew B. (Matt) Ferguson
Chief Financial Officer
Chief Financial Officer
488.10K
+1.64%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
328.54K
-21.31%
Dr. Michelle LeRoux Williams, Ph.D.
Dr. Michelle LeRoux Williams, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
126.28K
+6.52%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
125.00K
--
Mr. David Colpman
Mr. David Colpman
Independent Director
Independent Director
31.10K
--
Ms. Brigid A. Makes
Ms. Brigid A. Makes
Independent Director
Independent Director
27.00K
--
Dr. C. Randal (Randal) Mills, Ph.D.
Dr. C. Randal (Randal) Mills, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Matthew B. (Matt) Ferguson
Mr. Matthew B. (Matt) Ferguson
Chief Financial Officer
Chief Financial Officer
488.10K
+1.64%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
328.54K
-21.31%
Dr. Michelle LeRoux Williams, Ph.D.
Dr. Michelle LeRoux Williams, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
126.28K
+6.52%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
125.00K
--
Mr. David Colpman
Mr. David Colpman
Independent Director
Independent Director
31.10K
--
Ms. Brigid A. Makes
Ms. Brigid A. Makes
Independent Director
Independent Director
27.00K
--
FAQs
Who are the top five shareholders of Elutia Inc?
The top five shareholders of Elutia Inc are: Mr. Matthew B. (Matt) Ferguson
How many institutions hold shares of Elutia Inc (ELUT)?
As of 2026Q1, 59 institutions hold shares of Elutia Inc, with a combined market value of approximately 21.86M, accounting for 49.45% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -5893824.00.